Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma A/S (Nasdaq: ZEAL), a pioneering biotechnology company, is gearing up for an exciting series of investor conferences this September. With its commitment to the research and development of innovative peptide-based medicines, Zealand Pharma aims to engage with investors and showcase its latest advancements in the biotechnology sector.

Key Conferences in September

In September 2025, Zealand Pharma will participate in several high-profile investor conferences, designed to promote its innovative drug discovery initiatives. These conferences present an excellent opportunity for investors to gain insights directly from the company's leadership.

Jefferies Swiss Healthcare Summit 2025

This summit, taking place on September 3, will feature Adam Lange, Vice President of Investor Relations. He will conduct investor meetings throughout the day, providing attendees with an in-depth understanding of the company’s strategic direction and growth potential.

Cantor Global Healthcare Conference 2025

Also scheduled for September 3-5 in New York, this conference will include Adam Steensberg, the President and Chief Executive Officer of Zealand Pharma. On September 4, he is set to host meetings with investors, as well as partake in a fireside chat at 8:00am EDT (14:00 CET). The chat promises to be an engaging discussion about the current landscape of the biotechnology industry and Zealand Pharma's role within it.

Wells Fargo and Morgan Stanley Conferences

Following these events, Zealand Pharma will also participate in the 2025 Wells Fargo Healthcare Conference from September 3 to 5 in Boston. During this important gathering, Adam Steensberg will engage with investors on September 5 and contribute to a fireside chat at 8:45am EDT (14:45 CET).

Morgan Stanley Annual Healthcare Conference

Adam Lange will lead investor engagements at the Morgan Stanley Annual Healthcare Conference on September 10 in New York. This event will allow for valuable interactions between the company's leadership and potential investors.

Final Conferences and Presentations

Later in the month, Zealand Pharma will partake in the Bank of America Global Healthcare Conference from September 23 to 25 in London. David Kendall, Executive Vice President and Chief Medical Officer, will run meetings on September 24 and 25 and is scheduled to give a presentation on September 25 at 10:45 am UKT (11:45 CET). Additionally, an audio webcast link will be available for viewing later on the company’s website, allowing for broader access to interested parties.

KBC Securities Life Sciences Conference

The final conference in September will be the KBC Securities Life Sciences Conference in Brussels on September 25. Adam Lange will again represent the company, hosting meetings with investors to deepen connections and share updates on Zealand Pharma’s innovative portfolio.

About Zealand Pharma

Established in 1998 and headquartered in Copenhagen, Zealand Pharma A/S (Nasdaq: ZEAL) concentrates on the development of peptide-based drugs. Over the years, the company has successfully brought several drug candidates into clinical progress, with two gaining market approval and three in late-stage development phases. Its partnerships with various pharmaceutical companies enhance its market reach and operational capacity.

For additional details about Zealand Pharma, including updates on its initiatives and conferences, please visit www.zealandpharma.com.

Frequently Asked Questions

What is the focus of Zealand Pharma?

Zealand Pharma is dedicated to the discovery and development of innovative peptide-based medicines aimed at addressing unmet medical needs.

When will Zealand Pharma participate in its next investor conference?

Zealand Pharma will participate in several conferences throughout September, starting with the Jefferies Swiss Healthcare Summit on September 3.

Who will represent Zealand Pharma at these conferences?

Key representatives include Adam Lange, Vice President of Investor Relations, and Adam Steensberg, President and Chief Executive Officer.

Are there any webcasts available for the fireside chats?

Yes, there will be live audio webcasts for some sessions, with recordings available after the events for those unable to attend.

How many drug candidates has Zealand Pharma developed?

Zealand Pharma has pushed over ten drug candidates into clinical development, with several achieving market readiness.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.